Literature DB >> 25893433

Recommendations of the Spanish Brachytherapy Group of SEOR for HDR endoluminal treatments. Part 1: Oesophagus.

Á Rovirosa1, J Anchuelo, V Crispin, C Gutiérrez, A Herreros, I Herruzo, J C Menéndez, P Pino, A Polo, S Rodríguez.   

Abstract

The endoesophageal brachytherapy technique provides good results in the treatment of oesophageal cancer, when indicated. In a consensus meeting, the Spanish Brachytherapy Group of SEOR and the Spanish Society of Medical Physics (SEFM) agreed on the indications, dose, fractionation schedule, prescription and reporting to be performed in endoesophageal brachytherapy. The results of this consensus are presented here as recommendations for medical practice.

Entities:  

Mesh：

Year:  2015        PMID： 25893433     DOI： 10.1007/s12094-015-1284-0

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.405


  37 in total

1.  Radiation therapy alone for stage I (UICC T1N0M0) squamous cell carcinoma of the esophagus: indications for surgery or combined chemoradiotherapy.

Authors:  Hitoshi Ishikawa; Hideyuki Sakurai; Yoshio Tamaki; Tetsuo Nonaka; Michitaka Yamakawa; Yoshihiro Saito; Yoshizumi Kitamoto; Keiko Higuchi; Masatoshi Hasegawa; Takashi Nakano
Journal:  J Gastroenterol Hepatol       Date:  2006-08       Impact factor: 4.029

2.  External beam radiotherapy combined with intraluminal brachytherapy in esophageal carcinoma.

Authors:  Christina T Muijs; Jannet C Beukema; Veronique E Mul; John Th Plukker; Nanna M Sijtsema; Johannes A Langendijk
Journal:  Radiother Oncol       Date:  2011-08-30       Impact factor: 6.280

3.  Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial.

Authors:  H Bergquist; U Wenger; E Johnsson; J Nyman; H Ejnell; E Hammerlid; L Lundell; M Ruth
Journal:  Dis Esophagus       Date:  2005       Impact factor: 3.429

4.  Treatment results of chemoradiotherapy for clinical stage I (T1N0M0) esophageal carcinoma.

Authors:  Kazunari Yamada; Masao Murakami; Yoshiaki Okamoto; Yoshishige Okuno; Toshifumi Nakajima; Fusako Kusumi; Hiroshi Takakuwa; Satoru Matsusue
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-03-15       Impact factor: 7.038

5.  Long-term outcomes of intraluminal brachytherapy in combination with external beam radiotherapy for superficial esophageal cancer.

Authors:  Yuji Murakami; Yasushi Nagata; Ikuno Nishibuchi; Tomoki Kimura; Masahiro Kenjo; Yuko Kaneyasu; Tomoyuki Okabe; Yasutoshi Hashimoto; Yukio Akagi
Journal:  Int J Clin Oncol       Date:  2011-07-12       Impact factor: 3.402

6.  Retrospective analysis of definitive radiotherapy for patients with superficial esophageal carcinoma: Consideration of the optimal treatment method with a focus on late morbidity.

Authors:  Takeshi Kodaira; Nobukazu Fuwa; Hiroyuki Tachibana; Tatsuya Nakamura; Natsuo Tomita; Rie Nakahara; Haruo Inokuchi; Nobutaka Mizoguchi; Akinori Takada
Journal:  Radiother Oncol       Date:  2010-02-12       Impact factor: 6.280

7.  Clinical outcomes and prognostic factors for patients with early esophageal squamous cell carcinoma treated with definitive radiation therapy alone.

Authors:  Hitoshi Ishikawa; Hideyuki Sakurai; Michitaka Yamakawa; Yoshihiro Saito; Yuko Nakayama; Yoshizumi Kitamoto; Masahiko Okamoto; Kousaku Harada; Masatoshi Hasegawa; Takashi Nakano
Journal:  J Clin Gastroenterol       Date:  2005-07       Impact factor: 3.062

8.  External beam radiotherapy versus brachytherapy in the management of malignant oesophageal dysphagia: a retrospective study.

Authors:  H Eldeeb; S Reza; U Shmueli; G Logsdail; P Hinks; S Mukherjee
Journal:  J BUON       Date:  2012 Jul-Sep       Impact factor: 2.533

9.  Combined external and intraluminal radiotherapy in the treatment of advanced oesophageal cancer.

Authors:  Kimmo Hujala; Jukka Sipilä; Heikki Minn; Pertti Ruotsalainen; Reidar Grenman
Journal:  Radiother Oncol       Date:  2002-07       Impact factor: 6.280

10.  High dose rate brachytherapy (HDR-BT) in locally advanced oesophageal cancer. Clinic response and survival related to biological equivalent dose (BED).

Authors:  Maria C López Carrizosa; P Maria Samper Ots; A Rodríguez Pérez; A Sotoca; J Sáez Garrido; M M de Miguel
Journal:  Clin Transl Oncol       Date:  2007-06       Impact factor: 3.340
View more
  1 in total

1.  Why is a very easy, useful, old technique underused? An overview of esophageal brachytherapy - interventional radiotherapy.

Authors:  Albert Biete; György Kovács; Ángeles Rovirosa; Luca Tagliaferri; Adam Chicheł; Valentina Lancellotta; Yaowen Zhang; Gabriela Antelo; Peter Hoskin; Elzbieta Van Der Steen-Banasik
Journal:  J Contemp Brachytherapy       Date:  2022-06-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.